FCRL5 and Miyoshi myopathy: Peptides were designed from numerous Ags based on their level of expression and role in MM pathogenesis: B Cell Maturation Antigen (BCMA), Mucin1 (MUC1), Fc Receptor Like 5 (FcRH5), Myeloid Cell Leukemia 1 (MCL1), Receptor for Hyaluronan-Mediated Mobility (RHAMM), Self-Ligand Receptor of the Signaling Lymphocytic Activation Molecule Family 7 (SLAMF7), spliced isoform of X-Box Binding Protein 1 (XBP(S)1), Cancer Testis Antigen (CT45), Melanoma Antigen Family 3/6 (MAGEA3/6), New York Esophageal Squamous Cell Carcinoma 1 (NY-ESO-1), SEPTIN9 (SEPT9) and Wilms Tumor 1 (WT1).